نتائج البحث

乳腺癌芳香化酶抑制剂治疗期间骨丢失的长期随访结果.

• Authors : 陈茜¹; 孙婧²; 王琴³

• Source: Chinese Journal of Osteoporosis. 2023, Vol. 29 Issue 7, p992-997. 6p.

تفاصيل العنوان

芳香化酶抑制剂治疗晚期或复发性子宫内膜癌的研究进展.

• Authors : 张绍¹; 孔宪超¹

• Source: Journal of International Obstetrics & Gynecology. Feb2022, Vol. 49 Issue 1, p1-38. 5p.

تفاصيل العنوان

补肾活血法预防芳香化酶抑制剂所致骨丢失的机制.

• Authors : 浦冬青¹; 刘志勇²; 冯丹丹³

• Source: Chinese Journal of Osteoporosis. 2024, Vol. 30 Issue 8, p1127-1132. 6p.

تفاصيل العنوان

绝经后早期乳腺癌接受芳香化酶抑制剂治疗后骨丢失的前瞻性研究.

• Authors : 孙婧¹; 王琴²; 汪麟¹

• Source: Chinese Journal of Oncology. may2020, Vol. 42 Issue 5, p403-407. 5p.

تفاصيل العنوان

[A prospective study of bone loss in early stage postmenopausal breast cancer treated with aromatase inhibitors].

• Authors : Sun J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; Wang Q

Subjects: Postmenopause*; Aromatase Inhibitors/Aromatase Inhibitors/Aromatase Inhibitors/*therapeutic use ; Bone Density/Bone Density/Bone Density/*drug effects

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2020 May 23; Vol. 42 (5), pp. 403-407.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

تفاصيل العنوان

抑制生长板软骨细胞凋亡药物筛选及白藜芦醇延迟大鼠骨骺闭合的作用.

• Authors : 谢 艳¹; 李无阴¹; 邢伟鹏¹

• Source: Chinese Journal of Tissue Engineering Research / Zhongguo Zuzhi Gongcheng Yanjiu. 8/18/2022, Vol. 26 Issue 23, p3644-3649. 6p.

تفاصيل العنوان

[Menopausal symptoms and quality of life of hormone receptor positive breast cancer patients at different endocrine therapy time].

• Authors : Li X; West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 6l0041, China.; Wang H

Subjects: Aromatase Inhibitors*/Aromatase Inhibitors*/Aromatase Inhibitors*/therapeutic use ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/complications ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2020 Jan 23; Vol. 42 (1), pp. 55-60.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

تفاصيل العنوان

[Guidelines for pharmaceutical care of endocrine therapeutics for breast cancer(2023 edition)].

• Authors : National Cancer Center; Oncology Specialty Pharmacist Subcommittee, Chinese Pharmacists Association

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy; Humans ; Female

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2023 Oct 23; Vol. 45 (10), pp. 834-862.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

تفاصيل العنوان

乳腺癌内分泌治疗药物药学服务指南 (2023 版).

• Authors : 李国辉¹ ; 马飞¹

• Source: Chinese Journal of Oncology. Oct2023, Vol. 45 Issue 10, p834-862. 29p.

تفاصيل العنوان

乳腺癌患者芳香化酶抑制剂治疗前的绝经判定和治疗选择.

• Authors : 孟祥颖¹; 孙冰¹; 宋三泰¹

• Source: Chinese Journal of Oncology. 2019, Vol. 41 Issue 12, p953-958. 6p.

تفاصيل العنوان